Israeli Study Links GLP-1 Drugs to Rare Brain Disorder

Israeli Study Links GLP-1 Drugs to Rare Brain Disorder

स्वास्थ्य
इस घटना को पिन करने के लिए साइन इन करें

Israeli researchers identified 15 cases of Wernicke encephalopathy among users of GLP-1 weight-loss drugs in Israel, prompting calls for further investigation. Earlier reports noted that the study, which examined nearly 196,000 patients, found the cases were disproportionately linked to semaglutide and tirzepatide, highlighting a risk of severe vitamin-B1 deficiency.

अभिनेताओं

Israeli researchers semaglutide tirzepatide

स्थान

Israel

तथ्य जांच

ये मेट्रिक्स कैसे काम करती हैं
फ़ैसला: अपर्याप्त साक्ष्य विश्वास स्तर: 22%
एक नज़र में

All three claims stating that researchers or reviews identified 15 cases of Wernicke encephalopathy associated with GLP-1 receptor agonists, including semaglutide and tirzepatide, between September 11 and 13, 2026, have insufficient evidence.

पूर्ण विवरण अनलॉक करने के लिए साइन इन करें या सदस्यता लें: दावे, स्रोत और सत्यापन।

रजिस्टर करें साइन इन करें

इस अनुभाग में बाहरी स्रोतों के विरुद्ध दावों का स्वचालित सत्यापन है और इसमें अशुद्धियाँ हो सकती हैं।

लेख

15 सितंबर 2026
1 कुल
Study reveals possible link between GLP-1 weight loss drugs and rare brain condition
Study reveals possible link between GLP-1 weight loss drugs and rare brain condition

The Independent • 15 सितं 17:45

An Israeli review of FDA adverse-event reports identified 15 instances of Wernicke encephalopathy among users of GLP-1 medications, prompting calls for further investigation.

विश्वसनीयता 71% हेरफेर 9% मध्यस्थ
13 सितंबर 2026
2 कुल
Ozempic and Wegovy may cause rare brain disorder, new study warns
Ozempic and Wegovy may cause rare brain disorder, new study warns

Fox News • 13 सितं 17:00

A review of FDA reports and medical literature identified 15 cases of Wernicke encephalopathy among users of semaglutide and tirzepatide, prompting calls for further research.

विश्वसनीयता 68% हेरफेर 30% मध्यस्थ
Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder
Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder

Yahoo Health • 13 सितं 17:00

Researchers identified 15 reports of Wernicke encephalopathy in patients using GLP-1 receptor agonists, highlighting a possible link to vitamin B1 deficiency but noting the rarity of the condition.

विश्वसनीयता 68% हेरफेर 12% मध्यस्थ
12 सितंबर 2026
1 कुल
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study

NewsNation • 12 सितं 20:18

Researchers identified 15 cases of Wernicke encephalopathy in 2023-2024 among patients using GLP-1 agonists, highlighting a potential risk of severe thiamine deficiency.

विश्वसनीयता 72% हेरफेर 8% मध्यस्थ
11 सितंबर 2026
1 कुल
2 popular GLP-1 drugs linked to rare, life-threatening brain disorder
2 popular GLP-1 drugs linked to rare, life-threatening brain disorder

New York Post • 11 सितं 16:09

Research involving nearly 196,000 patients identified 15 cases of Wernicke encephalopathy, a serious condition linked to vitamin B1 deficiency, that were disproportionately associated with semaglutide and tirzepatide.

विश्वसनीयता 57% हेरफेर 27% मध्यस्थ

संबंधित घटनाएँ